Abstract

Amyotrophic lateral sclerosis (ALS) is a terminalneurodegenerative disease. Clinical and molecular observations suggest that ALS pathology originates at a single site and spreads in an organized and prion-like manner, possibly driven by extracellular vesicles. Extracellular vesicles (EVs) transfer cargo molecules associated with ALS pathogenesis, such as misfolded and aggregated proteins and dysregulated microRNAs (miRNAs). However, it is poorly understood whether altered levels of circulating extracellular vesicles or their cargo components reflect pathological signatures of the disease. In this study, we used immuno-affinity-based microfluidic technology, electron microscopy, and NanoString miRNA profiling to isolate and characterize extracellular vesicles and their miRNA cargo from frontal cortex, spinal cord, and serum of sporadic ALS (n = 15) and healthy control (n = 16) participants. We found larger extracellular vesicles in ALS spinal cord versus controls and smaller sized vesicles in ALS serum. However, there were no changes in the number of extracellular vesicles between cases and controls across any tissues. Characterization of extracellular vesicle-derived miRNA cargo in ALS compared to controls identified significantly altered miRNA levels in all tissues; miRNAs were reduced in ALS frontal cortex and spinal cord and increased in serum. Two miRNAs were dysregulated in all three tissues: miR-342-3p was increased in ALS, and miR-1254 was reduced in ALS. Additional miRNAs overlapping across two tissues included miR-587, miR-298, miR-4443, and miR-450a-2-3p. Predicted targets and pathways associated with the dysregulated miRNAs across the ALS tissues were associated with common biological pathways altered in neurodegeneration, including axon guidance and long-term potentiation. A predicted target of one identified miRNA (N-deacetylase and N-sulfotransferase 4; NDST4) was likewise dysregulated in an in vitro model of ALS, verifying potential biological relevance. Together, these findings demonstrate that circulating extracellular vesicle miRNA cargo mirror those of the central nervous system disease state in ALS, and thereby offer insight into possible pathogenic factors and diagnostic opportunities.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is a heterogeneous fatal neurodegenerative disorder

  • To better understand the role of dysregulated Extracellular vesicles (EVs) miRNAs in ALS pathology, we examined the functional Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, which correspond to the predicted DEmiRNA targets for each tissue using DIANA-mirPath analysis (Vlachos et al, 2015)

  • We addressed the potential roles of EVs in ALS using ExoChip immno-affinity microfluidic technology to isolate EVs from serum and post-mortem central nervous system (CNS) tissues from ALS cases and controls

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is a heterogeneous fatal neurodegenerative disorder. EVs contain molecular cargo from cells, such as genetic material, proteins, metabolites, and cellular waste, and travel via the circulation to recipient cells to execute specific cellular functions (Margolis and Sadovsky, 2019). Changes in EV levels and cargo content are associated with health and disease, as well as responses to extracellular stimuli (Datta Chaudhuri et al, 2019; Margolis and Sadovsky, 2019). EVs may promote neurodegeneration by transferring pathogenic molecules between neuronal and non-neuronal cells in a prion-like manner, which can “spread” disease (Soria et al, 2017; McAlary et al, 2020). EVs cross the blood-brain barrier (Saint-Pol et al, 2020), making them an attractive biomarker candidate for diseases of the central nervous system (CNS), including ALS. EV mobility, cargo, molecular mechanisms of action, and diagnostic implications are still not well understood in ALS, and continued research is needed (Gagliardi et al, 2021)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call